Burberry Group PLC announced that Dr. Gerry Murphy, the Chair and a Non-Executive Director, has purchased 20,000 Ordinary Shares of 0.05 pence each in the company on July 16, 2024, at an aggregate price of 725.0635 pence per Share. This transaction was disclosed in accordance with Article 19 of the EU Market Abuse Regulation 596/2014 as it forms part of UK law.

Dr. Gerard Martin Murphy, in his capacity as Chair and Non-Executive Director, made the initial notification of the transaction. The purchase of ordinary shares was conducted on the XLON platform, with an aggregated total of £145,012.70 for the 20,000 shares.

This announcement provides insight into the confidence of the company's leadership in its future prospects, as Dr. Murphy's purchase of shares demonstrates his belief in the company's performance and potential growth.